Bruno Vanderlinden
About
Bruno Vanderlinden is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Bruno Vanderlinden has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bruno Vanderlinden's work include Medical Imaging Techniques and Applications (23 papers), Radiomics and Machine Learning in Medical Imaging (14 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Bruno Vanderlinden is often cited by papers focused on Medical Imaging Techniques and Applications (23 papers), Radiomics and Machine Learning in Medical Imaging (14 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Bruno Vanderlinden collaborates with scholars based in Belgium, France and Netherlands. Bruno Vanderlinden's co-authors include Irène Buvat, Patrick Flamen, Camilo Garcia, Jacques-Antoine Maisonobe, Fanny Orlhac, Michaël Soussan, Alain Hendlisz, Daniel Devriendt, Marc Levivier and Lieveke Ameye and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.
In The Last Decade
Bruno Vanderlinden
36 papers receiving 1.4k citations
Peers
Bruno Vanderlinden
Henry Mandeville United Kingdom
R. Baum Germany
Elaine Johanna Limkin France
Darren M.C. Poon Hong Kong
Nalee Kim South Korea
Juliane Hörner‐Rieber Germany
J.H. Heinzerling United States
Zabi Wardak United States
Sarah Boughdad Switzerland
Hwa Kyung Byun South Korea
Citations per year, relative to Bruno Vanderlinden Bruno Vanderlinden (= 1×)
peers
Henry Mandeville
Countries citing papers authored by Bruno Vanderlinden
Since
Specialization
Citations
This map shows the geographic impact of Bruno Vanderlinden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Vanderlinden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Vanderlinden more than expected).
Fields of papers citing papers by Bruno Vanderlinden
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Bruno Vanderlinden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Vanderlinden. The network helps show where Bruno Vanderlinden may publish in the future.
Co-authorship network of co-authors of Bruno Vanderlinden
This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Vanderlinden. A scholar is included among the top collaborators of Bruno Vanderlinden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Vanderlinden. Bruno Vanderlinden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chan, David, Aimee R. Hayes, Ioannis Karfis, et al.. (2023). [18F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study. Journal of Nuclear Medicine. 65(2). 185–191.
2.
Tran‐Gia, Johannes, Carlos Uribe, Bruno Vanderlinden, et al.. (2023). Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera. EJNMMI Physics. 10(1). 64–64.
3.
Chan, David, Aimee R. Hayes, Ioannis Karfis, et al.. (2022). Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score. British Journal of Cancer. 128(4). 549–555.
4.
Levillain, Hugo, Thomas Guiot, Ákos Gulybán, et al.. (2020). Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer. EJNMMI Physics. 7(1). 75–75.
5.
Levillain, Hugo, Lieveke Ameye, Thomas Guiot, et al.. (2019). Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study. European Journal of Nuclear Medicine and Molecular Imaging. 46(11). 2270–2279.
6.
Levillain, Hugo, Thomas Guiot, Michaël Vouche, et al.. (2018). 90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer. EJNMMI Research. 8(1). 60–60.
7.
Vanderlinden, Bruno, Ioannis Karfis, Thomas Guiot, et al.. (2018). A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours. Physica Medica. 56. 41–49.
8.
Lucidi, Valério, Fikri Bouazza, Georgios Katsanos, et al.. (2018). Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study. HPB. 20(7). 641–648.
9.
Vanderlinden, Bruno, Ioannis Karfis, Thomas Guiot, et al.. (2017). Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy. EJNMMI Physics. 4(1). 7–7.
10.
Muylle, Kristoff, Patrick Flamen, Daniëlle J. Vugts, et al.. (2015). Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab. European Journal of Nuclear Medicine and Molecular Imaging. 42(8). 1304–1314.
11.
Vouche, Michaël, Riad Salem, Frank H. Miller, et al.. (2015). Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance. Clinical Imaging. 39(3). 454–462.
12.
Orlhac, Fanny, Michaël Soussan, Jacques-Antoine Maisonobe, et al.. (2014). Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis. Journal of Nuclear Medicine. 55(3). 414–422.
13.
Makris, Nikolaos, Ronald Boellaard, Eric P. Visser, et al.. (2013). Multicenter Harmonization of 89Zr PET/CT Performance. Journal of Nuclear Medicine. 55(2). 264–267.
14.
Maisonobe, Jacques-Antoine, Camilo Garcia, Bruno Vanderlinden, et al.. (2012). Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy. European Journal of Nuclear Medicine and Molecular Imaging. 40(2). 166–174.
15.
Hendlisz, Alain, V. Golfinopoulos, C. Garcia, et al.. (2011). Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy. Annals of Oncology. 23(7). 1687–1693.
16.
Garcia, C., Lieveke Ameye, Bruno Vanderlinden, et al.. (2010). Heterogeneity of Metabolic Response to Systemic Therapy in Metastatic Breast Cancer Patients. Clinical Oncology. 22(10). 818–827.
17.
Flamen, Patrick, Bruno Vanderlinden, Philippe Delatte, et al.. (2008). Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Physics in Medicine and Biology. 53(22). 6591–6603.
18.
Massager, Nicolas, Ouzi Nissim, Noriko Murata, et al.. (2006). Effect of beam channel plugging on the outcome of gamma knife radiosurgery for trigeminal neuralgia. International Journal of Radiation Oncology*Biology*Physics. 65(4). 1200–1205.
19.
Lorenzoni, José, Daniel Devriendt, Nicolas Massager, et al.. (2004). Radiosurgery for treatment of brain metastases: Estimation of patient eligibility using three stratification systems. International Journal of Radiation Oncology*Biology*Physics. 60(1). 218–224.
20.
Focan, C., A Baudoux, M. Beauduin, et al.. (1989). Adjuvant Treatment with High Dose Medroxyprogesterone Acetate in Node-Negative Early Breast Cancer A 3-year Interim Report on a Randomized Trial (I). Acta Oncologica. 28(2). 237–240.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Henry Mandeville Breakdown of academic impact, for papers by R. Baum Breakdown of academic impact, for papers by Elaine Johanna Limkin Breakdown of academic impact, for papers by Darren M.C. Poon Breakdown of academic impact, for papers by Nalee Kim Breakdown of academic impact, for papers by Juliane Hörner‐Rieber Breakdown of academic impact, for papers by J.H. Heinzerling Breakdown of academic impact, for papers by Zabi Wardak Breakdown of academic impact, for papers by Sarah Boughdad Breakdown of academic impact, for papers by Hwa Kyung Byun